Currently holds a position at Surface Oncology Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Surface Oncology Inc | Dec. 17, 2018 - |
President, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer | Surface Oncology Inc | None - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-01-14 | 2021-07-21 |
Surface Oncology Inc
(SURF)
|
S Sale |
127,778
-49.7%
6.10779,446 USD |
127,778 -49.7% | 6.10 | 779,446 USD | |
2021-06-11 | 2021-06-11 |
Surface Oncology Inc
(SURF)
|
S Sale |
15,273
-5.6%
7.61116,226 USD |
15,273 -5.6% | 7.61 | 116,226 USD | |
2021-06-11 | 2021-06-10 |
Surface Oncology Inc
(SURF)
|
S Sale |
234,727
-47.3%
7.661,798,619 USD |
234,727 -47.3% | 7.66 | 1,798,619 USD | |
2021-02-09 | 2021-02-08 |
Surface Oncology Inc
(SURF)
|
PS Planned sale |
2,500
-0.9%
12.5031,250 USD |
2,500 -0.9% | 12.50 | 31,250 USD | |
2021-02-03 | 2021-02-01 |
Surface Oncology Inc
(SURF)
|
PS Planned sale |
2,500
-0.9%
10.6926,718 USD |
2,500 -0.9% | 10.69 | 26,718 USD | |
2021-01-21 | 2021-01-19 |
Surface Oncology Inc
(SURF)
|
PS Planned sale |
5,000
-1.9%
13.0065,000 USD |
5,000 -1.9% | 13.00 | 65,000 USD | |
2020-02-07 | 2020-02-05 |
Surface Oncology Inc
(SURF)
|
B Purchase |
5,000
+1.9%
3.2316,150 USD |
5,000 +1.9% | 3.23 | 16,150 USD |